EE03305B1 - Paljuosaline tableteeritud annusvorm I - Google Patents
Paljuosaline tableteeritud annusvorm IInfo
- Publication number
- EE03305B1 EE03305B1 EE9600035A EE9600035A EE03305B1 EE 03305 B1 EE03305 B1 EE 03305B1 EE 9600035 A EE9600035 A EE 9600035A EE 9600035 A EE9600035 A EE 9600035A EE 03305 B1 EE03305 B1 EE 03305B1
- Authority
- EE
- Estonia
- Prior art keywords
- dosage form
- methoxy
- coating layer
- multiparticulate
- enteric coating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9402433A SE9402433D0 (sv) | 1994-07-08 | 1994-07-08 | New oral pharmaceutical dosage form |
SE9402432A SE9402432D0 (sv) | 1994-07-08 | 1994-07-08 | New pharmaceutical dosage form |
PCT/SE1995/000677 WO1996001623A1 (en) | 1994-07-08 | 1995-06-07 | Multiple unit tableted dosage form i |
Publications (1)
Publication Number | Publication Date |
---|---|
EE03305B1 true EE03305B1 (et) | 2000-12-15 |
Family
ID=26662095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9600035A EE03305B1 (et) | 1994-07-08 | 1995-06-07 | Paljuosaline tableteeritud annusvorm I |
Country Status (41)
Country | Link |
---|---|
US (1) | US5817338A (et) |
EP (2) | EP1078628B1 (et) |
JP (1) | JP3350054B2 (et) |
KR (1) | KR100384960B1 (et) |
CN (1) | CN1138534C (et) |
AT (2) | ATE414509T1 (et) |
AU (1) | AU695966B2 (et) |
BR (2) | BR9506018A (et) |
CA (1) | CA2170647C (et) |
CY (1) | CY2254B1 (et) |
CZ (1) | CZ289804B6 (et) |
DE (4) | DE69535889D1 (et) |
DK (2) | DK0723436T3 (et) |
DZ (1) | DZ1906A1 (et) |
EE (1) | EE03305B1 (et) |
ES (2) | ES2316333T3 (et) |
FI (1) | FI122017B (et) |
GR (1) | GR970300014T1 (et) |
HK (1) | HK1008300A1 (et) |
HR (1) | HRP950349B1 (et) |
HU (1) | HUT75775A (et) |
IL (1) | IL114450A (et) |
IS (1) | IS4327A (et) |
MA (1) | MA23607A1 (et) |
MX (1) | MX9600857A (et) |
MY (1) | MY112915A (et) |
NO (1) | NO314125B3 (et) |
NZ (1) | NZ289948A (et) |
PL (1) | PL180395B1 (et) |
PT (2) | PT1078628E (et) |
RU (2) | RU2160094C2 (et) |
SA (1) | SA95160091B1 (et) |
SI (2) | SI1078628T1 (et) |
SK (1) | SK283626B6 (et) |
TN (1) | TNSN95075A1 (et) |
TR (1) | TR199500821A2 (et) |
TW (1) | TW450813B (et) |
UA (1) | UA41946C2 (et) |
WO (1) | WO1996001623A1 (et) |
YU (1) | YU49236B (et) |
ZA (1) | ZA955548B (et) |
Families Citing this family (169)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6875872B1 (en) * | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SK283626B6 (sk) * | 1994-07-08 | 2003-10-07 | Astrazeneca Ab | Multijednotková tabletovaná dávková forma, spôsob jej prípravy a jej použitie |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US6279736B1 (en) | 1995-04-19 | 2001-08-28 | Capitol Specialty Plastics, Inc. | Barrier pack having an absorbing agent applied to the interior of the pack |
WO1997012581A2 (en) | 1995-09-21 | 1997-04-10 | Pharma Pass L.L.C. | Novel composition containing an acid-labile omeprazole and process for its preparation |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
SE9600072D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
SE508669C2 (sv) * | 1996-04-26 | 1998-10-26 | Astra Ab | Nytt förfarande |
SE9602442D0 (sv) * | 1996-06-20 | 1996-06-20 | Astra Ab | Administration of pharmaceuticals |
US6623759B2 (en) * | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
DE19637082A1 (de) | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
ATE271379T1 (de) * | 1996-11-06 | 2004-08-15 | Wockhardt Europ Ltd | System zur verzögerten freisetzung säurelabiler substanzen |
SE510666C2 (sv) * | 1996-12-20 | 1999-06-14 | Astra Ab | Nya Kristallmodifikationer |
ES2192265T3 (es) * | 1997-01-06 | 2003-10-01 | Pfizer | Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente. |
CZ291842B6 (cs) * | 1997-03-13 | 2003-06-18 | Hexal Ag | Farmaceutická formulace |
SE9702000D0 (sv) * | 1997-05-28 | 1997-05-28 | Astra Ab | New pharmaceutical formulation |
SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
US6747155B2 (en) | 1997-05-30 | 2004-06-08 | Astrazeneca Ab | Process |
SE510643C2 (sv) | 1997-06-27 | 1999-06-14 | Astra Ab | Termodynamiskt stabil omeprazol natrium form B |
SE9702533D0 (sv) | 1997-07-01 | 1997-07-01 | Astra Ab | New oral formulation |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6221402B1 (en) | 1997-11-20 | 2001-04-24 | Pfizer Inc. | Rapidly releasing and taste-masking pharmaceutical dosage form |
EE04800B1 (et) * | 1997-12-08 | 2007-04-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks |
SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
SE9704870D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
ATE526022T1 (de) | 1998-04-20 | 2011-10-15 | Eisai R&D Man Co Ltd | Stabilisierte zusammenstellungen die benzimidazole enthalten |
WO1999059544A2 (en) | 1998-05-18 | 1999-11-25 | Takeda Chemical Industries, Ltd. | Orally disintegrable tablets |
ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
SE9803772D0 (sv) | 1998-11-05 | 1998-11-05 | Astra Ab | Pharmaceutical formulation |
IL142703A (en) * | 1998-11-10 | 2006-04-10 | Astrazeneca Ab | Crystalline form of omeprazole |
JP3926936B2 (ja) | 1998-11-16 | 2007-06-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホキシド誘導体・アセトン錯体およびその製造法 |
SE9900274D0 (sv) | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
WO2000074654A1 (en) | 1999-06-07 | 2000-12-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel preparation and administration form comprising an acid-labile active compound |
IL130602A0 (en) * | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
SE0100823D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method I to obtain microparticles |
ES2168043B1 (es) | 1999-09-13 | 2003-04-01 | Esteve Labor Dr | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
EP1222922B1 (en) | 1999-10-20 | 2007-08-15 | Eisai R&D Management Co., Ltd. | Method for stabilizing benzimidazole compounds |
CA2290893C (en) | 1999-11-16 | 2007-05-01 | Bernard Charles Sherman | Magnesium omeprazole |
ES2244167T3 (es) * | 1999-12-16 | 2005-12-01 | Laboratorio Medinfar-Produtos Farmaceuticos, S.A. | Nuevas preparaciones farmaceuticas multiunitarias estables que contienen bencimidazoles sustituidos. |
SE0000774D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
US6544556B1 (en) * | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
BR0115986A (pt) | 2000-12-07 | 2003-12-23 | Altana Pharma Ag | Comprimido de desintegração rápida contendo um ingrediente ativo instável aos ácidos |
US20020192299A1 (en) * | 2000-12-28 | 2002-12-19 | Rajneesh Taneja | Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
SE0100822D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method II to obtain microparticles |
WO2002096394A2 (en) * | 2001-05-30 | 2002-12-05 | Euro-Celtique S.A. | Pharmaceutical composition containing stool softener such as polaxamer and enteric coated particles of bisacodyl |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
CA2453290A1 (en) * | 2001-07-16 | 2003-01-30 | Astrazeneca Ab | Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
EP1429745A2 (en) | 2001-09-28 | 2004-06-23 | McNEIL-PPC, INC. | Composite dosage forms having an inlaid portion |
ES2198195B1 (es) | 2001-12-18 | 2004-10-01 | Laboratorios Del Dr. Esteve, S.A. | Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido. |
MXPA04007169A (es) * | 2002-01-25 | 2004-10-29 | Santarus Inc | Suministro transmucosal de inhibidores de bomba de protones. |
CA2474246C (en) * | 2002-03-05 | 2010-06-29 | Astrazeneca Ab | Alkylammonium salts of omeprazole and esomeprazole |
US20040082618A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
JP2005536527A (ja) * | 2002-08-02 | 2005-12-02 | ラティオファルム ゲー・エム・ベー・ハー | 微結晶セルロースと混合したベンズイミダゾール化合物を含有する医薬製剤およびその製造方法 |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
EP1556010A4 (en) * | 2002-10-31 | 2007-12-05 | Supergen Inc | PHARMACEUTICAL FORMULATIONS TARGETING SPECIFIC REGIONS OF THE GASTROINTESTINAL TRACT |
US20040242642A1 (en) * | 2002-11-18 | 2004-12-02 | Dr. Reddy's Laboratories Limited | Crystalline esomeprazole compounds and process for the preparation thereof |
US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
US20040166162A1 (en) * | 2003-01-24 | 2004-08-26 | Robert Niecestro | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
US20040185119A1 (en) * | 2003-02-26 | 2004-09-23 | Theuer Richard C. | Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency |
CL2004000983A1 (es) | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
PE20050150A1 (es) | 2003-05-08 | 2005-03-22 | Altana Pharma Ag | Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo |
CA2529984C (en) * | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
WO2005004921A1 (en) * | 2003-07-11 | 2005-01-20 | Astrazeneca Ab | Solid composition comprising a proton pump inhibitor |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20050043359A1 (en) * | 2003-08-20 | 2005-02-24 | The Procter & Gamble Company | Kit for treatment of upper gastrointestinal tract conditions |
WO2005020954A2 (en) * | 2003-09-03 | 2005-03-10 | Agi Therapeutics Limited | Proton pump inhibitor formulations, and methods of preparing and using such formulations |
TWI372066B (en) | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
WO2005046634A2 (de) * | 2003-11-14 | 2005-05-26 | Siegfried Generics International Ag | Magensaftresistente verabreichungsform |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1753405A4 (en) * | 2004-06-10 | 2008-09-17 | Glatt Air Tech Inc | SLOW RELEASE PHARMACEUTICAL PREPARATION |
CA2570796A1 (en) * | 2004-06-15 | 2006-01-05 | Teva Pharmaceutical Industries Ltd. | Stable pharmaceutical formulations of benzimidazole compounds |
US8461187B2 (en) | 2004-06-16 | 2013-06-11 | Takeda Pharmaceuticals U.S.A., Inc. | Multiple PPI dosage form |
US20050281876A1 (en) | 2004-06-18 | 2005-12-22 | Shun-Por Li | Solid dosage form for acid-labile active ingredient |
CN101513391B (zh) * | 2004-06-29 | 2013-03-13 | 奈科明丹麦股份有限公司 | 水不溶性药快速释放药物组合物的制造方法及通过本方法得到的药物组合物 |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
ES2246149B1 (es) * | 2004-07-02 | 2007-06-01 | Esteve Quimica, S.A. | Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion. |
EP1621187A1 (en) * | 2004-07-26 | 2006-02-01 | AstraZeneca AB | Pharmaceutical multiparticulate tablet formulations and process for their preparation |
US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
WO2006045152A1 (en) * | 2004-10-29 | 2006-05-04 | Mayne Pharma International Pty Ltd | Improved tabletting process |
GB0427455D0 (en) * | 2004-12-15 | 2005-01-19 | Jagotec Ag | Dosage forms |
EP1830822A1 (en) * | 2004-12-24 | 2007-09-12 | LEK Pharmaceuticals D.D. | Stable pharmaceutical composition comprising an active substance in the form of solid solution |
US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
US10071060B2 (en) * | 2005-07-08 | 2018-09-11 | Bioventures, Llc | Asymmetrically coated table |
ES2278511B1 (es) * | 2005-07-28 | 2008-06-16 | Laboratorios Almirall S.A. | Comprimidos con perfil de disolucion mejorado. |
US20060165776A1 (en) * | 2005-08-31 | 2006-07-27 | Ramesh Sesha | Antidepressant oral pharmaceutical compositions |
US9440003B2 (en) * | 2005-11-04 | 2016-09-13 | Boston Scientific Scimed, Inc. | Medical devices having particle-containing regions with diamond-like coatings |
AR057181A1 (es) * | 2005-11-30 | 2007-11-21 | Astra Ab | Nueva forma de dosificacion de combinacion |
US8124779B2 (en) | 2005-12-05 | 2012-02-28 | Astrazeneca Ab | Process for the preparation of esomeprazole non-salt form |
US20070141151A1 (en) * | 2005-12-20 | 2007-06-21 | Silver David I | Lansoprazole orally disintegrating tablets |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
CN101453993A (zh) | 2006-04-03 | 2009-06-10 | 伊萨·奥迪迪 | 含有机溶胶涂层的受控释放递送物件 |
JP5844028B2 (ja) | 2006-04-04 | 2016-01-13 | ケージー アクキュイシチオン エルエルシー | 抗血小板薬及び酸阻害薬を含む経口剤形 |
US20090068263A1 (en) * | 2006-04-20 | 2009-03-12 | Themis Laboratories Private Limited | Multiple unit compositions |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
US9023400B2 (en) * | 2006-05-24 | 2015-05-05 | Flamel Technologies | Prolonged-release multimicroparticulate oral pharmaceutical form |
WO2007138606A2 (en) * | 2006-06-01 | 2007-12-06 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
US7713549B2 (en) * | 2006-06-30 | 2010-05-11 | Board Of Trustees Of The University Of Arkansas | Extended release perforated tablet |
WO2008047320A2 (en) * | 2006-10-17 | 2008-04-24 | Ranbaxy Laboratories Limited | Multiple unit tablet compositions of benzimidazole compounds |
AU2007317561A1 (en) | 2006-10-27 | 2008-05-15 | The Curators Of The University Of Missouri | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
US8352042B2 (en) * | 2006-11-28 | 2013-01-08 | The Alfred E. Mann Foundation For Scientific Research | Remote controls and ambulatory medical systems including the same |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
KR20170097787A (ko) | 2007-10-12 | 2017-08-28 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 음식 섭취와 관계없이 위장 장애를 치료하는 방법 |
JP2011512416A (ja) | 2008-02-20 | 2011-04-21 | ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ | オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法 |
EP2293782B1 (en) * | 2008-05-06 | 2015-08-12 | Dexcel Pharma Technologies Ltd. | Stable benzimidazole formulation |
DE102008045339A1 (de) | 2008-09-01 | 2010-03-04 | Stada Arzneimittel Ag | Pharmazeutisches Pellet |
EP2344139A1 (en) * | 2008-09-09 | 2011-07-20 | AstraZeneca AB | Method for delivering a pharmaceutical composition to patient in need thereof |
US8828953B2 (en) | 2009-04-20 | 2014-09-09 | NaZura BioHealth, Inc. | Chemosensory receptor ligand-based therapies |
US9901551B2 (en) | 2009-04-20 | 2018-02-27 | Ambra Bioscience Llc | Chemosensory receptor ligand-based therapies |
SG176724A1 (en) | 2009-06-25 | 2012-01-30 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080501A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
FR2959509B1 (fr) | 2010-05-03 | 2012-07-13 | Prod Chim Auxiliaires Et De Synthese | Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole |
WO2011144975A1 (en) * | 2010-05-15 | 2011-11-24 | Jubilant Life Sciences Limited | Multi-unit compositions |
IT1401284B1 (it) | 2010-08-06 | 2013-07-18 | Valpharma S P A | Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system). |
WO2012054523A2 (en) | 2010-10-19 | 2012-04-26 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
CA2851327C (en) * | 2011-11-02 | 2019-06-25 | Laboratorios Del Dr. Esteve, S.A. | Coated pellets of omeprazole |
EP2797600A4 (en) | 2011-12-28 | 2015-09-16 | Pozen Inc | IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID |
CN103040774B (zh) * | 2012-11-30 | 2015-03-04 | 上海信谊万象药业股份有限公司 | 埃索美拉唑镁肠溶片中埃索美拉唑镁的制粒包衣工艺 |
CN103044400A (zh) * | 2012-12-21 | 2013-04-17 | 北京华禧联合科技发展有限公司 | 埃索美拉唑镁盐及其制备方法 |
JP5934835B2 (ja) * | 2013-03-08 | 2016-06-15 | 富士フイルム株式会社 | 腸溶性細粒及び医薬組成物 |
EP2929885A1 (en) | 2014-04-11 | 2015-10-14 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of rivaroxaban and proton pump inhibitors |
US10130618B2 (en) | 2014-04-11 | 2018-11-20 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Pharmaceutical combinations of dabigatran and proton pump inhibitors |
MX2017004473A (es) * | 2014-10-08 | 2017-10-12 | Synthetic Biologics Inc | Formulaciones de betalactamasa y usos de las mismas. |
US20170182070A1 (en) | 2014-10-08 | 2017-06-29 | Mayne Pharma International Pty Ltd. | Controlled Release Doxycycline |
CN104586809A (zh) * | 2015-01-08 | 2015-05-06 | 浙江亚太药业股份有限公司 | 一种埃索美拉唑镁微丸肠溶片及制备方法 |
WO2016162754A1 (en) | 2015-04-07 | 2016-10-13 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions for minocycline |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
KR102419769B1 (ko) | 2016-08-11 | 2022-07-13 | 아다미스 파마슈티칼스 코포레이션 | 약물 조성물 |
AU2017339247B2 (en) * | 2016-10-06 | 2020-07-23 | Jubilant Generics Limited | Pharmaceutical suspension dosage form of benzimidazole compounds and process of preparation thereof |
KR101877350B1 (ko) | 2016-10-28 | 2018-08-09 | 한미약품 주식회사 | 에스오메프라졸 함유 복합 캡슐제 및 그 제조방법 |
CZ2017315A3 (cs) | 2017-06-02 | 2018-12-12 | Zentiva, K.S. | Dávkovací jednotka s PPI (inhibitory protonové pumpy) |
WO2019113493A1 (en) | 2017-12-08 | 2019-06-13 | Adamis Pharmaceuticals Corporation | Drug compositions |
KR102080023B1 (ko) | 2018-01-29 | 2020-02-21 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물 |
KR102006777B1 (ko) | 2018-01-29 | 2019-10-08 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제 |
MX2021001905A (es) | 2018-08-23 | 2021-04-28 | Chong Kun Dang Pharmaceutical Corp | Preparacion farmaceutica que tiene excelentes propiedades de disolucion, que contiene esomeprazol y bicarbonato de sodio. |
BR112022001287A2 (pt) | 2019-07-26 | 2022-04-12 | Chong Kun Dang Pharmaceutical Corp | Composição farmacêutica |
US20230058473A1 (en) | 2020-01-27 | 2023-02-23 | Towa Pharmaceutical Co., Ltd. | Esomeprazole oral preparation and method for producing the same |
KR102573842B1 (ko) | 2020-02-21 | 2023-09-01 | 주식회사 종근당 | 방출특성이 우수한 에스오메프라졸 및 탄산수소나트륨의 약제학적 조성물 |
KR20210012881A (ko) | 2020-02-28 | 2021-02-03 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 우수한 방출특성을 갖는 약제학적 제제 |
CN114569579B (zh) | 2020-12-02 | 2023-10-31 | 丽珠医药集团股份有限公司 | 肠溶微丸、其制备方法和包含它的制剂 |
CN115120569B (zh) * | 2022-07-07 | 2023-11-28 | 江苏中邦制药有限公司 | 一种去除微丸间静电的方法 |
KR20240030479A (ko) | 2022-08-31 | 2024-03-07 | 한올바이오파마주식회사 | 에스오메프라졸 및 제산제를 포함하는 약제학적 제제 및 이의 제조방법 |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1545612A (fr) * | 1967-06-15 | 1968-11-15 | Dausse Lab | Procédé de fabrication de comprimés |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
JPS5535031A (en) * | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
JPS5598120A (en) * | 1979-01-16 | 1980-07-25 | Shin Etsu Chem Co Ltd | Preparation of drug having enteric coating |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
US4340582A (en) * | 1981-01-15 | 1982-07-20 | Abbott Laboratories | Erythromycin base tablets |
US4377568A (en) * | 1981-08-12 | 1983-03-22 | Merck Sharp & Dohme (I.A.) Corp. | Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same |
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
JPS5973529A (ja) * | 1982-10-12 | 1984-04-25 | Sankyo Co Ltd | 被覆固形製剤の製造法 |
US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
US4518433A (en) * | 1982-11-08 | 1985-05-21 | Fmc Corporation | Enteric coating for pharmaceutical dosage forms |
GB2132887A (en) * | 1982-11-15 | 1984-07-18 | Procter & Gamble | Enteric-coated anti-inflammatory compositions |
SE8301182D0 (sv) | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
US4556552A (en) * | 1983-09-19 | 1985-12-03 | Colorcon, Inc. | Enteric film-coating compositions |
WO1985003436A1 (en) * | 1984-02-10 | 1985-08-15 | A/S Alfred Benzon | Diffusion coated multiple-units dosage form |
US4568560A (en) * | 1984-03-16 | 1986-02-04 | Warner-Lambert Company | Encapsulated fragrances and flavors and process therefor |
DE3524337A1 (de) * | 1985-07-08 | 1987-01-08 | Roehm Gmbh | Arzneimittelumhuellung |
SE450087B (sv) * | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
GB2189699A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US4759749A (en) * | 1986-05-27 | 1988-07-26 | Level 1 Technologies, Inc. | Heater for physiological fluids |
GB8630080D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
SE8803822D0 (sv) * | 1988-10-26 | 1988-10-26 | Novel dosage form | |
SE8804629D0 (sv) * | 1988-12-22 | 1988-12-22 | Ab Haessle | New therapeutically active compounds |
US5026559A (en) * | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
AU649456B2 (en) * | 1990-06-20 | 1994-05-26 | Astra Aktiebolag | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
YU48263B (sh) * | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
EP0519144B1 (en) * | 1991-06-21 | 1997-08-13 | Ilsan Ilac Ve Hammaddeleri Sanayi A.S. | New galenic process for omeprazole containing pellets |
JP3142919B2 (ja) * | 1991-11-06 | 2001-03-07 | 旭化成株式会社 | セルロース誘導体ラテックス及びその製法 |
US5160742A (en) * | 1991-12-31 | 1992-11-03 | Abbott Laboratories | System for delivering an active substance for sustained release |
EP0653935B1 (en) * | 1992-08-05 | 2002-05-08 | F.H. FAULDING & CO. LIMITED | Pelletised pharmaceutical composition |
US5330759A (en) * | 1992-08-26 | 1994-07-19 | Sterling Winthrop Inc. | Enteric coated soft capsules and method of preparation thereof |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SE9302396D0 (sv) | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
JP3017906B2 (ja) * | 1993-10-08 | 2000-03-13 | 信越化学工業株式会社 | 腸溶性コーティング剤分散液 |
CA2173506C (en) * | 1993-10-12 | 2006-05-09 | Tomohisa Matsushita | Enteric granule-containing tablets |
GB2285989A (en) * | 1994-01-28 | 1995-08-02 | Merck Frosst Canada Inc | Aqueous formulations for enteric coatings |
SK283626B6 (sk) * | 1994-07-08 | 2003-10-07 | Astrazeneca Ab | Multijednotková tabletovaná dávková forma, spôsob jej prípravy a jej použitie |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
-
1995
- 1995-06-07 SK SK301-96A patent/SK283626B6/sk not_active IP Right Cessation
- 1995-06-07 AU AU29937/95A patent/AU695966B2/en not_active Expired
- 1995-06-07 SI SI9530733T patent/SI1078628T1/sl unknown
- 1995-06-07 SI SI9530541T patent/SI0723436T1/xx unknown
- 1995-06-07 US US08/454,395 patent/US5817338A/en not_active Expired - Lifetime
- 1995-06-07 KR KR1019960701156A patent/KR100384960B1/ko not_active IP Right Cessation
- 1995-06-07 NZ NZ289948A patent/NZ289948A/en not_active IP Right Cessation
- 1995-06-07 RU RU96107115/14A patent/RU2160094C2/ru not_active IP Right Cessation
- 1995-06-07 CZ CZ1996732A patent/CZ289804B6/cs not_active IP Right Cessation
- 1995-06-07 RU RU96107115/15K patent/RU2531553C2/ru not_active IP Right Cessation
- 1995-06-07 AT AT00117629T patent/ATE414509T1/de active
- 1995-06-07 DE DE69535889T patent/DE69535889D1/de not_active Expired - Lifetime
- 1995-06-07 ES ES00117629T patent/ES2316333T3/es not_active Expired - Lifetime
- 1995-06-07 CN CNB951908154A patent/CN1138534C/zh not_active Expired - Lifetime
- 1995-06-07 DK DK95926054T patent/DK0723436T3/da active
- 1995-06-07 DE DE69522921T patent/DE69522921T2/de not_active Revoked
- 1995-06-07 CA CA002170647A patent/CA2170647C/en not_active Expired - Lifetime
- 1995-06-07 PL PL95313387A patent/PL180395B1/pl unknown
- 1995-06-07 UA UA96030835A patent/UA41946C2/uk unknown
- 1995-06-07 PT PT00117629T patent/PT1078628E/pt unknown
- 1995-06-07 BR BR9506018A patent/BR9506018A/pt not_active Application Discontinuation
- 1995-06-07 PT PT95926054T patent/PT723436E/pt unknown
- 1995-06-07 MX MX9600857A patent/MX9600857A/es unknown
- 1995-06-07 EP EP00117629A patent/EP1078628B1/en not_active Revoked
- 1995-06-07 DK DK00117629T patent/DK1078628T3/da active
- 1995-06-07 DE DE29522419U patent/DE29522419U1/de not_active Expired - Lifetime
- 1995-06-07 JP JP50424896A patent/JP3350054B2/ja not_active Expired - Lifetime
- 1995-06-07 HU HU9600573A patent/HUT75775A/hu not_active Application Discontinuation
- 1995-06-07 EE EE9600035A patent/EE03305B1/et unknown
- 1995-06-07 EP EP95926054A patent/EP0723436B1/en not_active Revoked
- 1995-06-07 WO PCT/SE1995/000677 patent/WO1996001623A1/en not_active Application Discontinuation
- 1995-06-07 ES ES95926054T patent/ES2100142T3/es not_active Expired - Lifetime
- 1995-06-07 DE DE0723436T patent/DE723436T1/de active Pending
- 1995-06-07 AT AT95926054T patent/ATE206044T1/de not_active IP Right Cessation
- 1995-06-15 TW TW084106117A patent/TW450813B/zh not_active IP Right Cessation
- 1995-06-20 HR HR950349A patent/HRP950349B1/xx not_active IP Right Cessation
- 1995-07-04 DZ DZ950083A patent/DZ1906A1/fr active
- 1995-07-04 ZA ZA955548A patent/ZA955548B/xx unknown
- 1995-07-04 IL IL11445095A patent/IL114450A/xx not_active IP Right Cessation
- 1995-07-05 YU YU44895A patent/YU49236B/sh unknown
- 1995-07-06 TR TR95/00821A patent/TR199500821A2/xx unknown
- 1995-07-06 MA MA23946A patent/MA23607A1/fr unknown
- 1995-07-07 TN TNTNSN95075A patent/TNSN95075A1/fr unknown
- 1995-07-08 MY MYPI95001919A patent/MY112915A/en unknown
- 1995-07-09 SA SA95160091A patent/SA95160091B1/ar unknown
-
1996
- 1996-03-04 IS IS4327A patent/IS4327A/is unknown
- 1996-03-07 NO NO19960950A patent/NO314125B3/no not_active IP Right Cessation
- 1996-03-07 FI FI961057A patent/FI122017B/fi not_active IP Right Cessation
-
1997
- 1997-05-06 BR BR1100458-4A patent/BR1100458A/pt active IP Right Review Request
- 1997-05-30 GR GR970300014T patent/GR970300014T1/el unknown
-
1998
- 1998-07-17 HK HK98109231A patent/HK1008300A1/xx not_active IP Right Cessation
-
2001
- 2001-12-17 CY CY0100048A patent/CY2254B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE03305B1 (et) | Paljuosaline tableteeritud annusvorm I | |
DK0854718T3 (da) | Hidtil ukendt sammensætning indeholdende en syrelabil benzimidazol og fremgangsmåde til fremstilling deraf | |
NO20042630L (no) | Tablettert, oral, enterisk belagt, farmasoytisk doseringsform inneholdende en syrelabil benzimidazol | |
RU96107097A (ru) | Составная единичная дозированная форма в виде таблетки, содержащая ингибитор протонного насоса |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
HC1A | Change of owner name | ||
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20091231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20101231 |